116 related articles for article (PubMed ID: 21955444)
21. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.
Kamijo S; Nakajima A; Kamata K; Kurosawa H; Yagita H; Okumura K
Rheumatology (Oxford); 2008 Apr; 47(4):442-50. PubMed ID: 18310134
[TBL] [Abstract][Full Text] [Related]
22. Role of the TWEAK/Fn14 pathway in autoimmune diseases.
Xu WD; Zhao Y; Liu Y
Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091
[TBL] [Abstract][Full Text] [Related]
23. TWEAK induces liver progenitor cell proliferation.
Jakubowski A; Ambrose C; Parr M; Lincecum JM; Wang MZ; Zheng TS; Browning B; Michaelson JS; Baetscher M; Wang B; Bissell DM; Burkly LC
J Clin Invest; 2005 Sep; 115(9):2330-40. PubMed ID: 16110324
[TBL] [Abstract][Full Text] [Related]
24. Structure of the extracellular domains of human and Xenopus Fn14: implications in the evolution of TWEAK and Fn14 interactions.
Pellegrini M; Willen L; Perroud M; Krushinskie D; Strauch K; Cuervo H; Day ES; Schneider P; Zheng TS
FEBS J; 2013 Apr; 280(8):1818-29. PubMed ID: 23438059
[TBL] [Abstract][Full Text] [Related]
25. A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.
Bover LC; Cardó-Vila M; Kuniyasu A; Sun J; Rangel R; Takeya M; Aggarwal BB; Arap W; Pasqualini R
J Immunol; 2007 Jun; 178(12):8183-94. PubMed ID: 17548657
[TBL] [Abstract][Full Text] [Related]
26. Role of TWEAK and Fn14 in tumor biology.
Winkles JA; Tran NL; Brown SA; Stains N; Cunliffe HE; Berens ME
Front Biosci; 2007 Jan; 12():2761-71. PubMed ID: 17127278
[TBL] [Abstract][Full Text] [Related]
27. Age-dependent effects of TWEAK/Fn14 receptor activation on neural progenitor cells.
Hamill CA; Michaelson JS; Hahm K; Burkly LC; Kessler JA
J Neurosci Res; 2007 Dec; 85(16):3535-44. PubMed ID: 17803219
[TBL] [Abstract][Full Text] [Related]
28. Proinflammatory effect of TWEAK/Fn14 interaction in human retinal pigment epithelial cells.
Ebihara N; Nakayama M; Tokura T; Iwatsu M; Ushio H; Murakami A
Curr Eye Res; 2009 Oct; 34(10):836-44. PubMed ID: 19895311
[TBL] [Abstract][Full Text] [Related]
29. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway.
Michaelson JS; Burkly LC
Results Probl Cell Differ; 2009; 49():145-60. PubMed ID: 19513634
[TBL] [Abstract][Full Text] [Related]
31. Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14).
Fick A; Lang I; Schäfer V; Seher A; Trebing J; Weisenberger D; Wajant H
J Biol Chem; 2012 Jan; 287(1):484-495. PubMed ID: 22081603
[TBL] [Abstract][Full Text] [Related]
32. TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.
Xu H; Okamoto A; Ichikawa J; Ando T; Tasaka K; Masuyama K; Ogawa H; Yagita H; Okumura K; Nakao A
Biochem Biophys Res Commun; 2004 May; 318(2):422-7. PubMed ID: 15120617
[TBL] [Abstract][Full Text] [Related]
33. TWEAK is a positive regulator of cardiomyocyte proliferation.
Novoyatleva T; Diehl F; van Amerongen MJ; Patra C; Ferrazzi F; Bellazzi R; Engel FB
Cardiovasc Res; 2010 Mar; 85(4):681-90. PubMed ID: 19887380
[TBL] [Abstract][Full Text] [Related]
34. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration.
Girgenrath M; Weng S; Kostek CA; Browning B; Wang M; Brown SA; Winkles JA; Michaelson JS; Allaire N; Schneider P; Scott ML; Hsu YM; Yagita H; Flavell RA; Miller JB; Burkly LC; Zheng TS
EMBO J; 2006 Dec; 25(24):5826-39. PubMed ID: 17124496
[TBL] [Abstract][Full Text] [Related]
35. TWEAK/Fn14 axis: the current paradigm of tissue injury-inducible function in the midst of complexities.
Burkly LC
Semin Immunol; 2014 Jun; 26(3):229-36. PubMed ID: 24636536
[TBL] [Abstract][Full Text] [Related]
36. TWEAK regulates proliferation and differentiation of adult neural progenitor cells.
Schölzke MN; Röttinger A; Murikinati S; Gehrig N; Leib C; Schwaninger M
Mol Cell Neurosci; 2011 Jan; 46(1):325-32. PubMed ID: 21040786
[TBL] [Abstract][Full Text] [Related]
37. A homogeneous HTRF assay for the identification of inhibitors of the TWEAK-Fn14 protein interaction.
Benicchi T; Iozzi S; Svahn A; Axelsson H; Mori E; Bernocco S; Cappelli F; Caramelli C; Fanti P; Genesio E; Maccari L; Markova N; Micco I; Porcari V; Schultz J; Fecke W
J Biomol Screen; 2012 Aug; 17(7):933-45. PubMed ID: 22644269
[TBL] [Abstract][Full Text] [Related]
38. Considering TWEAK as a target for therapy in renal and vascular injury.
Ortiz A; Sanz AB; Muñoz García B; Moreno JA; Sánchez Niño MD; Martín-Ventura JL; Egido J; Blanco-Colio LM
Cytokine Growth Factor Rev; 2009 Jun; 20(3):251-8. PubMed ID: 19482507
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-like weak inducer of apoptosis association with proliferative diabetic retinopathy and promotes proliferation and collagen synthesis in retinal ARPE-19 cells.
Chen DY; Su GF
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050952
[TBL] [Abstract][Full Text] [Related]
40. TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage.
Kaduka Y; Takeda K; Nakayama M; Kinoshita K; Yagita H; Okumura K
Biochem Biophys Res Commun; 2005 Jun; 331(2):384-90. PubMed ID: 15850771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
